🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eric Gonzalez

Akebia Therapeutics (United States)

ORCID: 0000-0002-3500-9668

Pharmacology, Toxicology and PharmaceuticsComputer ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development of Robust Quantitative Structure-Activity Relationship Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and Inhibition”.

Development of Robust Quantitative Structure-Activity Relationship Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and Inhibition

Drug Metabolism and Disposition(2021)10.1124/dmd.120.000320

N/A

0DataRank · unranked

40 citations

Sankalp Jain, Pranav Shah, Nao Torimoto‐Katori, Alexey Zakharov, Ðắc-Trung Nguyễn +8 more

Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform

Frontiers in Pharmacology(2022)10.3389/fphar.2022.899536

N/A

0DataRank · unranked

11 citations

Elias Carvalho Padilha, Pranav Shah, Ruili Huang, Srilatha Sakamuru, Eric Gonzalez +6 more

Pharmacokinetics and Pharmacodynamics of Nomlabofusp in Non-clinical Studies of Friedreich’s Ataxia

The AAPS Journal(2025)10.1208/s12248-025-01093-y

N/A

0DataRank · unranked

2 citations

Vanessa Ragaglia, Devin Schecter, Angela S. Miller, Eric Gonzalez, Erik Wagner +7 more